CN Patent

CN108794530A — 一种替诺福韦丙酚酰胺盐晶型及其制备方法和用途

Assigned to Shanghai Institute of Pharmaceutical Industry · Expires 2018-11-13 · 8y expired

What this patent protects

本发明公开了一种替诺福韦丙酚酰胺盐晶型及其制备方法和用途。本发明提供了一种如式I所示的替诺福韦丙酚酰胺盐的晶型甲，其X‑射线粉末衍射图在2θ值5.17±0.2°、7.30±0.2°、10.30±0.2°、10.91±0.2°、11.13±0.2°、18.55±0.2°、19.42±0.2°、21.14±0.2°和26.50±0.2°处有特征峰。该晶型具有制备简便、去除非对映异构体杂质能力强和稳定性高的优点。

USPTO Abstract

本发明公开了一种替诺福韦丙酚酰胺盐晶型及其制备方法和用途。本发明提供了一种如式I所示的替诺福韦丙酚酰胺盐的晶型甲，其X‑射线粉末衍射图在2θ值5.17±0.2°、7.30±0.2°、10.30±0.2°、10.91±0.2°、11.13±0.2°、18.55±0.2°、19.42±0.2°、21.14±0.2°和26.50±0.2°处有特征峰。该晶型具有制备简便、去除非对映异构体杂质能力强和稳定性高的优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN108794530A
Jurisdiction
CN
Classification
—
Expires
2018-11-13
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Institute of Pharmaceutical Industry
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.